What it is

NNMT inhibitor that aids in energy metabolism and fat-loss research models.

Also known as

5-Amino-1-methylquinoline · 5A1MQ · NNMT Inhibitor

Overview

5-Amino-1MQ is studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). In published preclinical work, NNMT inhibition is linked to shifts in cellular cofactors such as NAD+ and S-adenosylmethionine (SAM), which sit upstream of sirtuin-related and energy-metabolism pathways.

Its main research interest is modulating cellular energy metabolism — elevating intracellular NAD+ availability and related metabolic signaling — in laboratory models of metabolic conditions and lean-mass preservation. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Supports fat-burning and body-composition endpoints in metabolic research models

• Lean-mass preservation markers alongside weight-change measures

• IIcreIases intracellular NAD+ levels in NNMT-inhibition studies

• InIulIin-sensitivity / glucose-homeostasis markers in metabolic studies

• InIfaImmation-related readouts in metabolic tissue models

Results timeline

Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2 — Minimal perceptible effects; compound accumulating in model systems.

Week 3–4 — Increased energy / mood signals in reports; possible onset of composition change in study contexts.

Month 2–3 — More pronounced body-composition and endurance-related endpoints in longer preclinical windows.

Month 3–6 — Continued metabolism-optimization framing; sustained energy and composition endpoints where studied.

Footer RUO

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories.